Target- |
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date09 May 1997 |
100 Clinical Results associated with Avent, Inc.
0 Patents (Medical) associated with Avent, Inc.
100 Deals associated with Avent, Inc.
100 Translational Medicine associated with Avent, Inc.